Skip to main content Accessibility help
×
Home
Hostname: page-component-7ccbd9845f-dxj8b Total loading time: 0.946 Render date: 2023-02-02T02:52:20.195Z Has data issue: true Feature Flags: { "useRatesEcommerce": false } hasContentIssue true

Chapter 18 - Embolization for the Management of Uterine Fibroids

Published online by Cambridge University Press:  10 October 2020

Mostafa Metwally
Affiliation:
University of Sheffield
Tin-Chiu Li
Affiliation:
The Chinese University of Hong Kong
Get access

Summary

Uterine fibroids are the most common benign tumour in premenopausal women, with a lifetime prevalence of almost 70% in Caucasian women and more than 80% in women of Afro-Caribbean descent. About half of these women experience symptoms, with the most common being menorrhagia, dysmenorrhoea, pressure symptoms and infertility. Whilst hysterectomy is still the most commonly offered and performed operation to treat uterine fibroids, over the last 20 years minimally invasive therapies have been gaining popularity and uterine fibroid embolization is now a mainstream option for most women who wish to preserve their uterus. Since its introduction, a strong body of evidence has built demonstrating safety and efficacy with low rates of complication. Uterine fibroid embolization (UFE) was first described as a treatment for symptomatic leiomyomas in 1995 by Ravina et al. and has proved so popular that in the last year there were over 25,000 uterine fibroid embolization procedures performed worldwide [1].

Type
Chapter
Information
Publisher: Cambridge University Press
Print publication year: 2020

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Ravina, JH, Herbreteau, D, Ciraru-Vigneron, N, et al. Arterial embolization to treat uterine myomata. Lancet 1995;346:671–2.CrossRefGoogle ScholarPubMed
Chen, HT, Athreya, S. Systematic review of uterine artery embolization practice guidelines: are all the guidelines on the same page? Clin Radiol 2018;73:507.e9–15.CrossRefGoogle ScholarPubMed
Razavi, MK, Wolanske, KA, Hwang, GL, et al. Angiographic classification of ovarian artery-to-uterine artery anastomoses: initial observations in uterine fibroid embolization. Radiology 2002;224:707–12.CrossRefGoogle ScholarPubMed
Smeets, AJ, Nijenhuis, RJ, Boekkooi, PF, et al. Safety and effectiveness of uterine artery embolization in patients with pedunculated fibroids. J Vasc Interv Radiol 2009;20:1172–5.CrossRefGoogle ScholarPubMed
Rajan, DK, Margau, R, Kroll, RR, et al. Clinical utility of ultrasound versus magnetic resonance imaging for deciding to proceed with uterine artery embolization for presumed symptomatic fibroids. Clin Radiol 2011;66:5762.CrossRefGoogle ScholarPubMed
Kim, MD, Kim, YM, Kim, HC, et al. Uterine artery embolization for symptomatic adenomyosis: a new technical development of the 1-2-3 protocol and predictive factors of MR imaging affecting outcomes. J Vasc Interv Radiol 2011;22:497502.CrossRefGoogle ScholarPubMed
Binkert, CA, Hirzel, FC, Gutzeit, A, Zollikofer, CL, Hess, T. Superior hypogastric nerve block to reduce pain after uterine artery embolization: advanced technique and comparison to epidural anesthesia. Cardiovasc Intervent Radiol 2015;38:1157–61.CrossRefGoogle ScholarPubMed
Yoon, J, Valenti, D, Muchantef, K, et al. Superior hypogastric nerve block as post–uterine artery embolization analgesia: a randomized and double-blind clinical trial. Radiology 2018. https://doc.org/10.1148/radiol.2018172714CrossRefGoogle Scholar
Resnick, NJ, Kim, E, Patel, RS, et al. Uterine artery embolization using a transradial approach: initial experience and technique. J Vasc Interv Radiol; 2014;25:443–7.CrossRefGoogle ScholarPubMed
Posham, R, Biederman, DM, Patel, RS, et al. Transradial approach for noncoronary interventions: a single-center review of safety and feasibility in the first 1,500 cases. J Vasc Interv Radiol 2016;27:159–66.CrossRefGoogle ScholarPubMed
Hu, NN, Kaw, D, McCullough, MF, Nsouli-Maktabi, H, Spies, JB. Menopause and menopausal symptoms after ovarian artery embolization: a comparison with uterine artery embolization controls. J Vasc Interv Radiol 2011;22:710–1.CrossRefGoogle ScholarPubMed
Noel-Lamy, M, Tan, KT, Simons, ME, et al. Intraarterial lidocaine for pain control in uterine artery embolization: a prospective, randomized study. J Vasc Interv Radiol 2017;28:1622.CrossRefGoogle ScholarPubMed
Pelage, J-P, Guaou, NG, Jha, RC, Ascher, SM, Spies, JB. Uterine fibroid tumors: long-term MR imaging outcome after embolization. Radiology 2004;230:803–9.CrossRefGoogle ScholarPubMed
National Institute for Health and Care Excellence. Uterine artery embolization (Interventional procedures guidance [IPG367]). 2010. Available at www.nice.org.uk/guidance/IPG367. Accessed 22 May 2018.Google Scholar
Royal College of Obstetricians and Gynaecologists. Uterine artery embolization in the management of fibroids. 2013. Available at: www.rcog.org.uk/en/guidelines-research-services/guidelines/uterine-artery-embolization-in-the-management-of-fibroids. Accessed 22 May 2018.Google Scholar
Gupta, JK, Sinha, A, Lumsden, MA, Hickey, M. Uterine artery embolization for symptomatic uterine fibroids. Cochrane Database Syst Rev 2014;(12):CD005073.Google Scholar
van Overhagen, H, Reekers, JA. Uterine artery embolization for symptomatic leiomyomata. Cardiovasc Intervent Radiol 2015;38:536–42.CrossRefGoogle ScholarPubMed
Myers, ER, Goodwin, S, Landow, W, et al. Prospective data collection of a new procedure by a specialty society: the FIBROID registry. Obstet Gynecol 2005;106:4451.CrossRefGoogle ScholarPubMed
de Bruijn, AM, Ankum, WM, Reekers, JA, et al. Uterine artery embolization vs hysterectomy in the treatment of symptomatic uterine fibroids: 10-year outcomes from the randomized EMMY trial. Am J Obstet Gynecol 2016;215:745.e1–12.CrossRefGoogle ScholarPubMed
Moss, JG, Cooper, KG, Khaund, A, et al. Randomised comparison of uterine artery embolization (UAE) with surgical treatment in patients with symptomatic uterine fibroids (REST trial): 5-year results. BJOG 2011;118:936–44.CrossRefGoogle ScholarPubMed
Dutton, S, Hirst, A, McPherson, K, Nicholson, T, Maresh, M. A UK multicentre retrospective cohort study comparing hysterectomy and uterine artery embolization for the treatment of symptomatic uterine fibroids (HOPEFUL study): main results on medium-term safety and efficacy. BJOG 2007;114:1340–51.CrossRefGoogle ScholarPubMed
McPherson, K, Manyonda, I, Lumsden, M-A, et al. A randomised trial of treating fibroids with either embolization or myomectomy to measure the effect on quality of life among women wishing to avoid hysterectomy (the FEMME study): study protocol for a randomised controlled trial. Trials 2014;15:100–11.CrossRefGoogle ScholarPubMed
Carpenter, TT, Walker, WJ. Pregnancy following uterine artery embolization for symptomatic fibroids: a series of 26 completed pregnancies. BJOG 2005;112:321–5.CrossRefGoogle ScholarPubMed
Goldberg, J, Pereira, L, Berghella, V, et al. Pregnancy outcomes after treatment for fibromyomata: uterine artery embolization versus laparoscopic myomectomy. Am J Obstet Gynecol 2004;191:1821.CrossRefGoogle ScholarPubMed
Homer, H, Saridogan, E. Uterine artery embolization for fibroids is associated with an increased risk of miscarriage. Fertil Steril 2010;94:324–30.CrossRefGoogle ScholarPubMed
Pisco, JM, Duarte, M, Bilhim, T, Cirurgiao, F, Oliveira, AG. Pregnancy after uterine fibroid embolization. Fertil Steril 2011;95:1121.e8.CrossRefGoogle ScholarPubMed
Mohan, PP, Hamblin, MH, Vogelzang, RL. Uterine artery embolization and its effect on fertility. J Vasc Interv Radiol 2013;24:925–30.CrossRefGoogle ScholarPubMed
Pron, G, Bennett, J, Common, A, et al. The Ontario Uterine Fibroid Embolization Trial. Part 2. Uterine fibroid reduction and symptom relief after uterine artery embolization for fibroids. Fertil Steril 2003 Jan;79(1):120–7.CrossRefGoogle ScholarPubMed
Kitson, SJ, Macphail, S, Bulmer, J. Is pregnancy safe after uterine artery embolization? BJOG 2012;119:519–21.CrossRefGoogle Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×